Compare EMN & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMN | CRL |
|---|---|---|
| Founded | 1920 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.0B |
| IPO Year | 1993 | 2000 |
| Metric | EMN | CRL |
|---|---|---|
| Price | $66.94 | $217.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $78.54 | ★ $203.58 |
| AVG Volume (30 Days) | ★ 1.3M | 677.1K |
| Earning Date | 01-29-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.01 | N/A |
| Revenue | ★ $9,024,000,000.00 | $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.35 | $1.70 |
| P/E Ratio | $11.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.11 | $91.86 |
| 52 Week High | $103.82 | $228.88 |
| Indicator | EMN | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 66.67 |
| Support Level | $65.51 | $214.11 |
| Resistance Level | $70.40 | $227.51 |
| Average True Range (ATR) | 1.92 | 7.17 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 46.40 | 72.15 |
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.